Personally, with the stem cell merger, the sky is the limit. Just look at the business model, of helping debilitated patients and the model scale up this company has. LAHO (post merger) is a global company not just here in the USA! That to me spells tons of profit potential. All in my humble opinion. Look past LAHO and see the regenerative model and potential help for millions, of people globally with varying disease processes. Also, remember biotech is a fast and highly profitable stock play. The LAHO parabolic sail is catching a sea breeze. aimho
I do not provide investment advice. This post is my personal opinion.